【高濃度ビタミンC点滴】
がん治療に併用する補助療法として海外で臨床研究が進められ、安全性は複数の早期臨床試験で確認されています。一方で有効性は研究段階で、手術・薬物療法・放射線治療といった標準治療に代わるものではありません。
当院では30g以上の高用量プランをご用意。実施前にG6PD欠損症の検査が必要です。
※自由診療（全額自己負担）／承認された用法ではありません
▶︎ LINE：https://lin.ee/34hk7oj
がん治療に併用する補助療法として海外で臨床研究が進められ、安全性は複数の早期臨床試験で確認されています。一方で有効性は研究段階で、手術・薬物療法・放射線治療といった標準治療に代わるものではありません。
当院では30g以上の高用量プランをご用意。実施前にG6PD欠損症の検査が必要です。
※自由診療（全額自己負担）／承認された用法ではありません
▶︎ LINE：https://lin.ee/34hk7oj
September 22, 2026 at 7:32 AM
【高濃度ビタミンC点滴】
がん治療に併用する補助療法として海外で臨床研究が進められ、安全性は複数の早期臨床試験で確認されています。一方で有効性は研究段階で、手術・薬物療法・放射線治療といった標準治療に代わるものではありません。
当院では30g以上の高用量プランをご用意。実施前にG6PD欠損症の検査が必要です。
※自由診療（全額自己負担）／承認された用法ではありません
▶︎ LINE：https://lin.ee/34hk7oj
がん治療に併用する補助療法として海外で臨床研究が進められ、安全性は複数の早期臨床試験で確認されています。一方で有効性は研究段階で、手術・薬物療法・放射線治療といった標準治療に代わるものではありません。
当院では30g以上の高用量プランをご用意。実施前にG6PD欠損症の検査が必要です。
※自由診療（全額自己負担）／承認された用法ではありません
▶︎ LINE：https://lin.ee/34hk7oj
Costunolide dimeric triazoles—compound 19 is 35× more potent against HCC than the parent, highly selective. Arrests G₂/M, blocks EMT, triggers apoptosis & ferroptosis. Targets G6PD, a metabolic vulnerability of liver cancer. Natural-inspired precision for HCC.
doi.org/10.1016/S187...
doi.org/10.1016/S187...
September 18, 2026 at 8:12 AM
Costunolide dimeric triazoles—compound 19 is 35× more potent against HCC than the parent, highly selective. Arrests G₂/M, blocks EMT, triggers apoptosis & ferroptosis. Targets G6PD, a metabolic vulnerability of liver cancer. Natural-inspired precision for HCC.
doi.org/10.1016/S187...
doi.org/10.1016/S187...
G6PD Deficiency is a genetic disorder that causes hemolytic anemia (red blood cells just dying off) when exposed to legumes, menthol, sulfa drugs, and other oxidizing things. We receive less than 500 dollars a month to be able to afford everything that is non food and they reduced our SNAP as well.
September 15, 2026 at 11:25 AM
G6PD Deficiency is a genetic disorder that causes hemolytic anemia (red blood cells just dying off) when exposed to legumes, menthol, sulfa drugs, and other oxidizing things. We receive less than 500 dollars a month to be able to afford everything that is non food and they reduced our SNAP as well.
I had to post here because Facebook is actively muting/blocking anyone that is asking for help, to the point where the word help automatically gets you muted and you can't even find your own posts.
I'm a mom with 3 kids at home, all of us have g6pd deficiency.
I'm a mom with 3 kids at home, all of us have g6pd deficiency.
September 15, 2026 at 11:25 AM
I had to post here because Facebook is actively muting/blocking anyone that is asking for help, to the point where the word help automatically gets you muted and you can't even find your own posts.
I'm a mom with 3 kids at home, all of us have g6pd deficiency.
I'm a mom with 3 kids at home, all of us have g6pd deficiency.
Takayasu Arteritis in a G6PD Deficient Female Patient With Recurrent Axillary Artery Stenosis: A Case Report
Takayasu Arteritis in a G6PD Deficient Female Patient With Recurrent Axillary Artery Stenosis: A Case Report - PubMed
Takayasu arteritis should be suspected in young females with limb claudication, absent pulses, recurrent arterial stenosis, and elevated inflammatory markers. Early diagnosis is crucial to prevent com...
pubmed.ncbi.nlm.nih.gov
September 12, 2026 at 11:19 PM
Takayasu Arteritis in a G6PD Deficient Female Patient With Recurrent Axillary Artery Stenosis: A Case Report
Comscore: l'estate traina lo smartphone. Comparto News a +5,5%, volano Paramount e Disney
https://vivere.me/g6PD-k
Comscore: l'estate traina lo smartphone. Comparto News a +5,5%, volano Paramount e Disney
vivere.me
September 10, 2026 at 2:49 PM
Comscore: l'estate traina lo smartphone. Comparto News a +5,5%, volano Paramount e Disney
G6PD Antibody Market Size, Trends & Forecast 2035 - Wiseguy | WiseGuyReports www.wiseguyreports.com/reports/g6pd...
G6PD Antibody Market Size, Trends & Forecast 2035 - Wiseguy
The G6PD Antibody Market is expected to grow from 800 USD Million in 2025 to 1,500 USD Million by 2035. The G6PD Antibody Market CAGR (growth rate) is expected to be around 5.9% | Wiseguy Reports
www.wiseguyreports.com
September 10, 2026 at 12:14 PM
G6PD Antibody Market Size, Trends & Forecast 2035 - Wiseguy | WiseGuyReports www.wiseguyreports.com/reports/g6pd...
G6PD Antibody Market Size, Trends & Forecast 2035 - Wiseguy | WiseGuyReports www.wiseguyreports.com/reports/g6pd...
G6PD Antibody Market Size, Trends & Forecast 2035 - Wiseguy
The G6PD Antibody Market is expected to grow from 800 USD Million in 2025 to 1,500 USD Million by 2035. The G6PD Antibody Market CAGR (growth rate) is expected to be around 5.9% | Wiseguy Reports
www.wiseguyreports.com
September 9, 2026 at 1:30 PM
G6PD Antibody Market Size, Trends & Forecast 2035 - Wiseguy | WiseGuyReports www.wiseguyreports.com/reports/g6pd...
G6PD Antibody Market Size, Trends & Forecast 2035 - Wiseguy | WiseGuyReports www.wiseguyreports.com/reports/g6pd...
G6PD Antibody Market Size, Trends & Forecast 2035 - Wiseguy
The G6PD Antibody Market is expected to grow from 800 USD Million in 2025 to 1,500 USD Million by 2035. The G6PD Antibody Market CAGR (growth rate) is expected to be around 5.9% | Wiseguy Reports
www.wiseguyreports.com
September 8, 2026 at 10:33 AM
G6PD Antibody Market Size, Trends & Forecast 2035 - Wiseguy | WiseGuyReports www.wiseguyreports.com/reports/g6pd...
LZTFL1 rewires NADPH-glutathione metabolism to amplify ferroptosis
LZTFL1 rewires NADPH-glutathione metabolism to amplify ferroptosis
Xue et al. identify LZTFL1 as a key regulator of ferroptosis that rewires GSH metabolism by promoting G6PD oxidation. GSH depletion enhances LZTFL1 translation, forming a feedforward circuit that amplifies ferroptosis. Restoring LZTFL1 re-sensitizes cisplatin-resistant tumors, highlighting its potential as a biomarker and therapeutic target.
dlvr.it
September 4, 2026 at 11:32 AM
LZTFL1 rewires NADPH-glutathione metabolism to amplify ferroptosis
לא רוצה להשמע אידיוט, אבל תורמוס זה לא צמח אחר לגמרי מפול ונחשב בטוח גם לחסרי g6pd?
August 25, 2026 at 5:33 PM
לא רוצה להשמע אידיוט, אבל תורמוס זה לא צמח אחר לגמרי מפול ונחשב בטוח גם לחסרי g6pd?
לשאלתך יש אידיוטיים שהציעו תורמוס(פול מיובש) לילד עם מחסור ב g6pd
August 25, 2026 at 5:24 PM
לשאלתך יש אידיוטיים שהציעו תורמוס(פול מיובש) לילד עם מחסור ב g6pd
רגע יש פול בתחליפי בשר? טוב לדעת לבנזוג יש חוסר בg6pd
August 25, 2026 at 5:08 PM
רגע יש פול בתחליפי בשר? טוב לדעת לבנזוג יש חוסר בg6pd
Thailand Medical Researchers Find Triphala May Protect Fragile Blood Cells
www.thailandmedical.news/news/thailan...
www.thailandmedical.news/news/thailan...
Thailand Medical Researchers Find Triphala May Protect Fragile Blood Cells - Thailand Medical News
Thai researchers have uncovered promising evidence that Triphala, a traditional herbal preparation made from three medicinal fruits, could help protect red blood cells from oxidative damage, including cells from people with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Triphala extract significantly reduced oxidative destruction of G6PD-deficient red blood cells in laboratory experimen...
www.thailandmedical.news
August 20, 2026 at 4:55 AM
Thailand Medical Researchers Find Triphala May Protect Fragile Blood Cells
www.thailandmedical.news/news/thailan...
www.thailandmedical.news/news/thailan...
Evidence for G6PD variant classification from multiplexed functional assays
Current and former Dunham and Fowler Lab members are authors on paper in Genome Biology.
link.springer.com/article/10.1...
Current and former Dunham and Fowler Lab members are authors on paper in Genome Biology.
link.springer.com/article/10.1...
Evidence for G6PD variant classification from multiplexed functional assays - Genome Biology
Background G6PD deficiency is one of the most common enzyme deficiencies worldwide, and increases the likelihood of adverse reactions to certain drugs and foods. As availability of routine sequencing ...
link.springer.com
August 19, 2026 at 5:43 PM
Evidence for G6PD variant classification from multiplexed functional assays
Current and former Dunham and Fowler Lab members are authors on paper in Genome Biology.
link.springer.com/article/10.1...
Current and former Dunham and Fowler Lab members are authors on paper in Genome Biology.
link.springer.com/article/10.1...
Point-of-care G6PD testing removes three critical barriers to safe, curative primaquine therapy for vivax malaria in endemic regions, enabling treatment decisions at the bedside.
https://news.gmj.ge/briefs/three-reasons-point-of-care-g6pd-testing-changes-vivax-malaria-treatment/
https://news.gmj.ge/briefs/three-reasons-point-of-care-g6pd-testing-changes-vivax-malaria-treatment/
Three Reasons Point-of-Care G6PD Testing Changes Vivax Malaria Treatment
Point-of-care G6PD testing removes three critical barriers to safe, curative primaquine therapy for vivax malaria in endemic regions, enabling treatment decisions at the bedside.
news.gmj.ge
August 10, 2026 at 2:52 PM
Point-of-care G6PD testing removes three critical barriers to safe, curative primaquine therapy for vivax malaria in endemic regions, enabling treatment decisions at the bedside.
https://news.gmj.ge/briefs/three-reasons-point-of-care-g6pd-testing-changes-vivax-malaria-treatment/
https://news.gmj.ge/briefs/three-reasons-point-of-care-g6pd-testing-changes-vivax-malaria-treatment/
We are excited to invite you to the next ILH Spotlight Papers session: two studies explore the complex interactions between metabolism, the tumor microenvironment & lung cancer.
Thursday, August 13, 2026
5:00 PM
Online via Zoom
#LungCancer #CancerResearch #SpatialProteomics #Macrophages #NSCLC
Thursday, August 13, 2026
5:00 PM
Online via Zoom
#LungCancer #CancerResearch #SpatialProteomics #Macrophages #NSCLC
August 10, 2026 at 7:45 AM
We are excited to invite you to the next ILH Spotlight Papers session: two studies explore the complex interactions between metabolism, the tumor microenvironment & lung cancer.
Thursday, August 13, 2026
5:00 PM
Online via Zoom
#LungCancer #CancerResearch #SpatialProteomics #Macrophages #NSCLC
Thursday, August 13, 2026
5:00 PM
Online via Zoom
#LungCancer #CancerResearch #SpatialProteomics #Macrophages #NSCLC
I continue to find G6PD just a fascinating gene. So much genetic variation. Balancing selection since deficiency can be protective against malaria. Interesting tech challenges too: the human gene can rescue the yeast zwf1 knockout, and we competed the mutant library in turbidostats to tune selection
August 10, 2026 at 1:50 AM
I continue to find G6PD just a fascinating gene. So much genetic variation. Balancing selection since deficiency can be protective against malaria. Interesting tech challenges too: the human gene can rescue the yeast zwf1 knockout, and we competed the mutant library in turbidostats to tune selection
Our deep mutational scan of G6PD is out in final form! @reneegeck.bsky.social did an incredible job on the project, & @dougfowler.bsky.social has been fantastic to collaborate with, as usual. Really gratifying to contribute functional evidence on VUS classification for G6PD deficiency. rdcu.be/fyTlf
Evidence for G6PD variant classification from multiplexed functional assays
rdcu.be
August 10, 2026 at 1:44 AM
Our deep mutational scan of G6PD is out in final form! @reneegeck.bsky.social did an incredible job on the project, & @dougfowler.bsky.social has been fantastic to collaborate with, as usual. Really gratifying to contribute functional evidence on VUS classification for G6PD deficiency. rdcu.be/fyTlf
RRID:AB_10646429 from @proteintech.bsky.social was used by authors in their Cell Death & Disease paper. We value the author's support of reproducibility. #OpenScience #RRID #methodsmatter
RACK1 governs a dual metabolic switch in lung adenocarcinoma through c-Src/G6PD and TRIM21/LDHA Axes - Cell Death & Disease
Read the full paper: RACK1 governs a dual metabolic switch in lung adenocarcinoma through c-Src/G6PD and TRIM21/LDHA Axes
doi.org
August 9, 2026 at 7:01 AM
RRID:AB_10646429 from @proteintech.bsky.social was used by authors in their Cell Death & Disease paper. We value the author's support of reproducibility. #OpenScience #RRID #methodsmatter
Online Now: LZTFL1 rewires NADPH-glutathione metabolism to amplify ferroptosis Online now:
LZTFL1 rewires NADPH-glutathione metabolism to amplify ferroptosis
Xue et al. identify LZTFL1 as a key regulator of ferroptosis that rewires GSH metabolism by promoting G6PD oxidation. GSH depletion enhances LZTFL1 translation, forming a feedforward circuit that amplifies ferroptosis. Restoring LZTFL1 re-sensitizes cisplatin-resistant tumors, highlighting its potential as a biomarker and therapeutic target.
dlvr.it
August 4, 2026 at 10:57 PM
Online Now: LZTFL1 rewires NADPH-glutathione metabolism to amplify ferroptosis Online now:
G6PD 缺乏的七個絕對禁忌藥
Dapsone、methylene blue、nitrofurantoin、phenazopyridine（Pyridium）、primaquine、rasburicase、toluidine blue。
腫瘤科情境特別要記 rasburicase —— 治療 TLS 時給下去會引發嚴重溶血與變性血紅素血症。
Aspirin 在治療劑量下一般安全，磺醯脲類（如 glibenclamide）也可安全使用。
#血液專科
https://hema-2026.hsiehting.com/q/110-049
Dapsone、methylene blue、nitrofurantoin、phenazopyridine（Pyridium）、primaquine、rasburicase、toluidine blue。
腫瘤科情境特別要記 rasburicase —— 治療 TLS 時給下去會引發嚴重溶血與變性血紅素血症。
Aspirin 在治療劑量下一般安全，磺醯脲類（如 glibenclamide）也可安全使用。
#血液專科
https://hema-2026.hsiehting.com/q/110-049
August 4, 2026 at 6:46 AM
G6PD 缺乏的七個絕對禁忌藥
Dapsone、methylene blue、nitrofurantoin、phenazopyridine（Pyridium）、primaquine、rasburicase、toluidine blue。
腫瘤科情境特別要記 rasburicase —— 治療 TLS 時給下去會引發嚴重溶血與變性血紅素血症。
Aspirin 在治療劑量下一般安全，磺醯脲類（如 glibenclamide）也可安全使用。
#血液專科
https://hema-2026.hsiehting.com/q/110-049
Dapsone、methylene blue、nitrofurantoin、phenazopyridine（Pyridium）、primaquine、rasburicase、toluidine blue。
腫瘤科情境特別要記 rasburicase —— 治療 TLS 時給下去會引發嚴重溶血與變性血紅素血症。
Aspirin 在治療劑量下一般安全，磺醯脲類（如 glibenclamide）也可安全使用。
#血液專科
https://hema-2026.hsiehting.com/q/110-049
G6PD 在台灣與新生兒的兩個事實
台灣的變異型並非全屬 Class III —— 常見的 G6PD Canton 與 Kaiping 屬 Class II（重度缺乏）。
新生兒黃疸多與遺傳性膽紅素代謝變異（如 UGT1A1）及溶血本身有關，不一定有藥物誘因。
女性雜合子因 lyonization 呈鑲嵌，同樣可能發病。
#血液專科
https://hema-2026.hsiehting.com/q/111-090
台灣的變異型並非全屬 Class III —— 常見的 G6PD Canton 與 Kaiping 屬 Class II（重度缺乏）。
新生兒黃疸多與遺傳性膽紅素代謝變異（如 UGT1A1）及溶血本身有關，不一定有藥物誘因。
女性雜合子因 lyonization 呈鑲嵌，同樣可能發病。
#血液專科
https://hema-2026.hsiehting.com/q/111-090
August 4, 2026 at 5:12 AM
G6PD 在台灣與新生兒的兩個事實
台灣的變異型並非全屬 Class III —— 常見的 G6PD Canton 與 Kaiping 屬 Class II（重度缺乏）。
新生兒黃疸多與遺傳性膽紅素代謝變異（如 UGT1A1）及溶血本身有關，不一定有藥物誘因。
女性雜合子因 lyonization 呈鑲嵌，同樣可能發病。
#血液專科
https://hema-2026.hsiehting.com/q/111-090
台灣的變異型並非全屬 Class III —— 常見的 G6PD Canton 與 Kaiping 屬 Class II（重度缺乏）。
新生兒黃疸多與遺傳性膽紅素代謝變異（如 UGT1A1）及溶血本身有關，不一定有藥物誘因。
女性雜合子因 lyonization 呈鑲嵌，同樣可能發病。
#血液專科
https://hema-2026.hsiehting.com/q/111-090
G6PD 缺乏的因果方向
G6PD 缺乏 → NADPH 生成「減少」、NADPH/NADP⁺ 比值「下降」→ 還原型 glutathione 不足 → 無法清除 H₂O₂ → 氧化性溶血與 Heinz body。
說「NADPH 增加造成 H₂O₂ 堆積」是把方向寫反。
紅血球唯一的 NADPH 來源就是這條 pentose phosphate pathway。
#血液專科
https://hema-2026.hsiehting.com/q/111-090
G6PD 缺乏 → NADPH 生成「減少」、NADPH/NADP⁺ 比值「下降」→ 還原型 glutathione 不足 → 無法清除 H₂O₂ → 氧化性溶血與 Heinz body。
說「NADPH 增加造成 H₂O₂ 堆積」是把方向寫反。
紅血球唯一的 NADPH 來源就是這條 pentose phosphate pathway。
#血液專科
https://hema-2026.hsiehting.com/q/111-090
August 4, 2026 at 5:11 AM
G6PD 缺乏的因果方向
G6PD 缺乏 → NADPH 生成「減少」、NADPH/NADP⁺ 比值「下降」→ 還原型 glutathione 不足 → 無法清除 H₂O₂ → 氧化性溶血與 Heinz body。
說「NADPH 增加造成 H₂O₂ 堆積」是把方向寫反。
紅血球唯一的 NADPH 來源就是這條 pentose phosphate pathway。
#血液專科
https://hema-2026.hsiehting.com/q/111-090
G6PD 缺乏 → NADPH 生成「減少」、NADPH/NADP⁺ 比值「下降」→ 還原型 glutathione 不足 → 無法清除 H₂O₂ → 氧化性溶血與 Heinz body。
說「NADPH 增加造成 H₂O₂ 堆積」是把方向寫反。
紅血球唯一的 NADPH 來源就是這條 pentose phosphate pathway。
#血液專科
https://hema-2026.hsiehting.com/q/111-090